tiprankstipranks
Trending News
More News >
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ

Jazz Pharmaceuticals (JAZZ) Revenue

Compare
1,677 Followers

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had a revenue of 897.84M in the quarter ending Mar 31, 2025, with -17.49%. This bring the company's revenue in the last twelve months to 4.06B, Increased -0.10%. In the fiscal year ending Dec 31, 2024, Jazz Pharmaceuticals had annual revenue of 4.07B with 6.12% growth.
Revenue (ttm)
4.06B
Revenue Growth
5.76%
P/S Ratio
1.64
Revenue/Employee
$1,453,196
Employees
2,800
Market Cap
$6.69B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
4.07B234.75M+6.12%
Dec 31, 2023
3.83B174.83M+4.78%
Dec 31, 2022
3.66B565.14M+18.26%
Dec 31, 2021
3.09B730.67M+30.91%
Dec 31, 2020
2.36B201.81M+9.34%
Dec 31, 2019
2.16B270.84M+14.32%
Dec 31, 2018
1.89B272.23M+16.82%
Dec 31, 2017
1.62B130.72M+8.79%
Dec 31, 2016
1.49B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis